Role of Potassium-Competitive Acid Blockers in Helicobacter pylori Eradication
The first-line therapy for Helicobacter pylori infection comprises triple therapy with the combination of a proton pump inhibitor (PPI), amoxicillin, and clarithromycin. However, the H. pylori eradication rate after PPI-based triple therapy has fallen below 80% in many countries, and even reached 70...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Yong Chan Lee
2017-03-01
|
Series: | The Korean Journal of Helicobacter and Upper Gastrointestinal Research |
Subjects: | |
Online Access: | http://www.helicojournal.org/journal/view.html?doi=10.7704/kjhugr.2017.17.1.20 |